## WELL: Welltower Inc. - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_20 -9.2% below STRENGTH zone (4.0-10.0%); PEG 3.62 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-9.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($176.23)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Sei Investments Co. Cuts Stock Holdings in Welltower Inc. $WELL**
- Source: MarketBeat | 20251211T132555 | Somewhat-Bullish | Relevance: 99%
- Sei Investments Co. reduced its stake in Welltower Inc. (NYSE:WELL) by 1.8% during the second quarter, selling 47,548 shares and retaining 2,524,323 shares valued at approximately $388 million. Despite this reduction, other institutional investors like State Street Corp, Norges Bank, and Wellington Management Group LLP significantly increased their holdings in the real estate investment trust. The article also provides a financial overview of Welltower, including its trading performance, recent earnings, dividend announcement, and analyst ratings, which generally recommend a "Moderate Buy."

**2. Welltower Inc. $WELL Stock Holdings Increased by First Trust Advisors LP**
- Source: MarketBeat | 20251210T120835 | Bullish | Relevance: 99%
-  First Trust Advisors LP has increased its holdings in Welltower Inc. (NYSE:WELL) by 19.5%, now owning 241,216 shares valued at $37.08 million. This increase reflects a positive sentiment, with analysts assigning a "Moderate Buy" rating and an average price target of $195.87 for the real estate investment trust. Welltower, with a market cap of approximately $134.3 billion, operates in health care infrastructure and posted earnings that beat consensus estimates in its last report.

**3. Axa S.A. Acquires 72,276 Shares of Welltower Inc. $WELL**
- Source: MarketBeat | 20251209T083504 | Bullish | Relevance: 99%
-  Axa S.A. increased its stake in Welltower Inc. by 15.6% during the second quarter, purchasing an additional 72,276 shares and bringing its total holdings to 535,170 shares valued at approximately $82.3 million. Analyst sentiment for Welltower is positive, with a consensus "Moderate Buy" rating and several firms raising price targets, including UBS to $232. Welltower also reported strong third-quarter earnings, beating estimates with $1.34 EPS, and announced a $0.74 quarterly dividend with a 1.5% yield.

**4. State Street Corp Buys 1,740,196 Shares of Welltower Inc. $WELL**
- Source: MarketBeat | 20251209T140847 | Somewhat-Bullish | Relevance: 98%
- State Street Corp increased its stake in Welltower Inc. (NYSE:WELL) by 4.6% during the second quarter, purchasing an additional 1,740,196 shares. Other institutional investors also adjusted their holdings in the real estate investment trust. Welltower reported strong financial performance, with its stock opening at $200.89 and analysts maintaining a "Moderate Buy" rating with an average target price of $195.87.

**5. Welltower (WELL): Assessing Valuation After Strong FFO Growth and Improving Senior Housing Fundamentals**
- Source: Simply Wall Street | 20251210T050917 | Somewhat-Bullish | Relevance: 98%
-  Welltower (WELL) recently reported strong financial growth, including over 20% year-over-year FFO growth and 15% same-store NOI, driven by improved senior housing demand. Despite recent share price dips, the stock has seen significant returns over 90 days and year-to-date. The article assesses Welltower's valuation, noting its high price-to-earnings ratio compared to peers but a slight overvaluation according to discounted cash flow models.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 11 ($0.05M) |
| Sells | 1 ($0.01M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 51.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Vanguard Group Inc: 13.1% (+4.7%)
- Blackrock Inc.: 10.1% (+4.3%)
- Capital Internationa: 6.8% (+4.1%)
- State Street Corpora: 6.0% (+4.1%)
- Cohen & Steers Inc.: 4.9% (-4.6%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-9.6% 5d) with bearish MACD, trend may be turning.
2. Valuation stretched: PEG 3.6x requires aggressive growth execution.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 3.62 signals overvaluation risk, limited margin of safety. Balance sheet: strong liquidity (5.4x). Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $127.0B |
| Beta | 0.84 |
| 52W Range | $123.11 - $209.05 |
| Short Interest | 2.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.62 |
| Forward P/E | 76.1 |
| Current P/E | 110.7 |
| YoY Growth | 45.4% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 0.4% to -9.2% (-9.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 13.2pp (needs >4.0% for momentum thesis). AM_20 at -7.2% indicates price below own 20MA trend. Underperforming sector by 6.8pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.13x) but short-term weakness (below SMA20). MACD histogram bearish (-2.63), momentum weakening. Elevated volume (1.4x 20MA), institutional activity likely.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -9.19% (CS: 2) | Weak |
| RSI_14 | 35.2 | Neutral |
| MACD Histogram | -2.63 | Bearish |
| vs SMA20 | 0.928x | Below |
| vs SMA50 | 0.991x | Below |
| vs SMA200 | 1.130x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $184.97
- **Stop Loss:** $176.23 (4.7% risk)
- **Target:** $193.71 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 157
- **Position Value:** $29,040.29
- **Portfolio %:** 29.04%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-09 (Est: $0.59)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.53 | $0.55 | +3.1% |
| 2025Q2 | $0.44 | $0.45 | +3.4% |
| 2025Q1 | $0.38 | $0.40 | +5.3% |
| 2024Q4 | $0.41 | $0.34 | -17.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*